自身免疫性肺泡蛋白沉积症的自发缓解:病例系列
本文报告3例自身免疫性肺泡蛋白沉积症(PAP)病例,均表现为静息低氧血症,未接受显著治疗即出现自发缓解。3例均有职业性有害气体吸入暴露史,在持续停止暴露后病情改善。作者假设职业或环境有害吸入暴露可能参与部分自身免疫性PAP的疾病表达,此类病例在停止暴露后可能自发缓解。
要点
- 自身免疫性PAP患者若有职业性有害气体暴露史,停止暴露后可能自发缓解。
- 静息低氧血症的自身免疫性PAP病例中,自发缓解虽罕见但需考虑。
- 询问职业吸入暴露史对自身免疫性PAP的评估和管理有潜在价值。
核心结论
- 职业或环境有害吸入暴露可能参与部分自身免疫性PAP的疾病表达,停止暴露后此类病例可能自发缓解。
研究设计与样本
- 病例系列,报告3例表现为静息低氧血症的自身免疫性PAP病例。
主要发现
- 3例自身免疫性PAP患者均表现为静息低氧血症,未接受显著治疗即自发缓解。
- 3例均有职业性有害气体吸入暴露史,在持续停止暴露后病情改善。
临床怎么用
- 对自身免疫性PAP患者应询问职业性有害气体吸入暴露史。
- 对存在相关暴露的患者,持续停止暴露可能促进病情自发缓解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pulmonary alveolar proteinosis (PAP) is a rare lung condition characterized by the accumulation of proteinaceous material within the alveoli. The acquired form is often autoimmune, driven by autoantibodies against granulocyte-macrophage colony-stimulating factor. Presentation of autoimmune PAP may range from incidental detection in asymptomatic patients to advanced respiratory failure. Treatment typically involves whole lung lavage or granulocyte-macrophage colony-stimulating factor therapy in symptomatic patients; spontaneous resolution is rare in severe cases. Here, we report 3 cases of autoimmune PAP who presented with resting hypoxia and exhibited spontaneous resolution without significant treatment. All 3 cases had a history of occupational inhalational exposure to noxious gases, and they improved following sustained cessation of exposure. We hypothesize that occupational or environmental noxious inhalation exposure may have a role in disease expression in some cases of autoimmune PAP, and such cases may show spontaneous resolution following cessation of the offending exposure.
引用
- Sahoo S, Saxena P, Ravi AK, et al. Spontaneous Resolution in Autoimmune Pulmonary Alveolar Proteinosis: A Case Series. Chest. 2025. PMID: 40506130. doi:10.1016/j.chest.2025.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。